2023 AALAS Use of Colony Metrics to Reduce Excess Animal Production in Dynamic Biotechnology Environment

Preclinical studies in animals are essential to help discover and develop candidate therapies for human diseases. Default strategy is often to produce animals in excess to prevent major delays in advancing molecules. In collaboration with Denali, we aim to improve animal usage by developing a colony metrics reporting tool to optimize colony usage.